VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NNOX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NNOXNano-X Imaging Ltd.
$0.29$20M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
NNOX logo

Nano-X Imaging Ltd.

NNOX
NASDAQ · Medical Imaging & Radiation
$0.29
At close - Nov 17, 4:00 PM EST - USD
Market Cap$20M
P/E-0.2x
52W High$4.71
Volume1.4M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2025Q4

Persistent Operating Losses Challenge Commercialization Scaling Efforts

Nano-X Imaging faces a precarious financial outlook as its transition to a hardware-as-a-service model struggles to overcome significant structural cost burdens.

GrowthMixed
ProfitabilityNegative
ValuationReview
TechnicalsWeak
Explore valuation models
MARKET ACTION

NNOX price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

3/12 Beats

EPS beat 3 of last 12 quarters

02

Valuation risk

-101% Peers

P/E is 101% below peer median

03

Market leadership

RS 3 · Lag

Laggard (Underperforming 97% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystConfirmed earnings · Nov 19

Market performance

Price History →

Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
NNOX-89.84%
S&P 500 (^GSPC)+7.21%
1-Year Return
NNOX-89.84%
S&P 500 (^GSPC)+10.03%
3-Year Return
NNOX-95.60%
S&P 500 (^GSPC)+55.91%
5-Year Return
NNOX-98.56%
S&P 500 (^GSPC)+54.92%

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$13M+15.4% YoY
Net income FY25
-$75M-40.2% YoY
Free cash flow FY25
-$45M-14.3% YoY
Operating margin FY25
-466.2%+36.8 pts YoY
ROIC (FY25)-35.6%
Avg ROIC 5Y-33.7%
ROE (TTM)-94.3%
Piotroski Score2 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate3/12 (27%)
Revenue Beat Rate0/12 (0%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Sep 9, 2026
-$0.79-387.6%
vs -$0.16
$4M-22.7%
vs $5M
Q3 2026
Jun 25, 2026
-$0.20-42.9%
vs -$0.14
$4M-29.5%
vs $6M
Q2 2026
Apr 20, 2026
-$0.50-117.4%
vs -$0.23
$4M-12.5%
vs $4M
Q4 2025
Nov 20, 2025
-$0.21+1.6%
vs -$0.21
$3M-1.6%
vs $4M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
GlobeNewsWire·2d ago
Nanox to Report Third Quarter 2026 Financial Results on November 25, 2026

PETACH TIKVA, Israel, Nov. 16, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced that it will report its financial results for the quarter ended September 30, 2026, before market open on Wednesday, November 25, 2026. Erez Meltzer, Chief Executive Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m.

GlobeNewsWire·5d ago
Nanox Announces Distribution Agreement with Medworks for Nanox.AI in Greece

Building on Nanox.AI's existing deployment in Athens, the agreement supports commercial expansion in Greece through  Medworks ' established market presence.

GlobeNewsWire·Nov 10, 2026
Nanox.AI Advances Commercial Collaboration with Dosy Health to Bring AI Cardiac Solution to Thailand

Collaboration builds on  Dosy Health's established relationships with Mahidol University, Thammasat University and hospitals within the BDMS network, supporting planned distribution and commercialization in Thailand PETACH TIKVA, Israel, [DATE] (GLOBE NEWSWIRE) -- Nano-X Imaging Ltd. (NASDAQ: NNOX) (“Nanox” or the “Company”), a leader in innovative medical imaging technology , today announced that its subsidiary, Nanox AI Ltd.

GlobeNewsWire·Nov 9, 2026
Nanox Announces That Board Has Approved Cost Reduction and Operational Efficiency Measures

The Board approved plan target s a 25%–30% reduction in annualized operating expenses, compared to annualized 2026 GAAP and non-GAAP operating expenses, once fully implemented, expected by the end of Q 1 202 7 Cost reduction aims to a dvanc e four strategic priorities: Nanox.ARC and N anox Imaging Network (N IN ) commercialization; commercial partnerships and business development; operational efficiency; and strengthening financial resources Cost initiatives are intended to improve resource s allocation while preserving critical product-development , regulatory and commercial capabilities PETACH TIKVA, Israel, Nov. 09, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced that the Board of Directors of the Company (the “Board”) has approved a plan to reduce costs and improve operational efficiency. The plan approved by the Board is in addition to the Company's previously announced cost reduction initiatives, including the restructuring of its South Korea operations, and is expected to reduce the Company's operating expenses, extend its cash resources and enable the Company to focus on its core priorities.

Filtered for Nano-X Imaging Ltd.More Headlines
04

Compare before deciding

Benchmark NNOX against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Nano-X Imaging Ltd. (NNOX)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
NNOX logoNNOXNano-X Imaging Ltd.Current
$0.29$20.01M-0.1715.4%-747.19%-94.35%—
HOLO logoHOLOMicroCloud Hologram Inc.
$1.01$13.31M2.2335.27%5.82%1.43%—
ATEC logoATECAlphatec Holdings, Inc.
$6.94$1.07B-12.5724.95%-10.35%-547.17%—
PRCT logoPRCTPROCEPT BioRobotics Corporation
$23.78$1.35B-11.8737.22%-32.6%-33.23%—
GEHC logoGEHCGE HealthCare Technologies Inc.
$81.84$36.97B21.064.84%8.54%15.87%0.17%
SYK logoSYKStryker Corporation
$317.54$121.73B33.7211.16%13.78%15.61%1.06%

Compare NNOX vs Peers

Nano-X Imaging Ltd. (NNOX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HOLO

Most directly comparable listed peer for NNOX.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare NNOX against a more recognizable public peer.

Peer Set

Compare Top 5

vs HOLO, ATEC, PRCT, GEHC

Get notified when NNOX posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

NNOX Frequently Asked Questions

Nano-X Imaging Ltd. (NNOX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Nano-X Imaging Ltd.'s revenue?

Nano-X Imaging Ltd. (NNOX) reported $15.6M in revenue over the trailing twelve months. Revenue was $13.0M in fiscal year 2025.

How fast is Nano-X Imaging Ltd. growing?

Nano-X Imaging Ltd. (NNOX) grew revenue by 31.5% over the trailing twelve months, compared with the twelve months before.

Is NNOX profitable?

No. Nano-X Imaging Ltd. (NNOX) reported a net loss of $116.8M over the trailing twelve months.

Dividend & Returns
What is NNOX's return on equity?

Nano-X Imaging Ltd. (NNOX) had a return on equity (ROE) of -94.3% over the trailing twelve months. A negative ROE means the company lost money over the period.

What is Nano-X Imaging Ltd.'s free cash flow?

Nano-X Imaging Ltd. (NNOX) had negative free cash flow of $53.3M over the trailing twelve months.

What if you invested $1,000 in NNOX back in 2018?

Total return calculator · dividends reinvested · 8+ years of data

See returns →